Researchers transplanted collagen sponge scaffolds containing LTα1β2, CCL19, CCL21, CXCL12, CXCL13, and soluble RANK ligands, which over time resulted in the development of immune-competent artificial TLSs with potential applications for cancer treatment (196). Here, CCL19 is linked to cancer.